Second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) updated second interim evaluation : evaluation support study on Horizon Europe's contribution to a resilient Europe

The purpose of this report is to provide the European Commission with the updated second interim evaluation of the second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) with a specific focus on its performance between 2017 and 2022. Its performance is assessed on the five key evaluation criteria set out in the Better Regulation Guidelines (i.e. relevance, coherence, efficiency, effectiveness and EU value added) and the partnership-specific criteria (i.e. additionality, directionality, international positioning & visibility, transparency & openness, and phasing out preparedness).